Bishal Gyawali, Associate Professor at Queen’s University, shared a post on X about the article co-authored with Kristina Jenei et al., published in The Lancet Oncology:
“The pervasive narrative in the media/news about Canada being the last country among G7 to approve cancer drugs or to approve fewest cancer drugs is objectively false. I know because my group has studied this. Link in next comment.
Context- this TorontoStar article that cites worry from both Prime Minister of Canada and Doug Ford regarding Canada being the worst among G7 countries regarding access to cancer drugs. But that’s not true.”
Title: Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study
Journal: The Lancet Oncology
Authors: Kristina Jenei, Adam J. N. Raymakers, Arnaud Bayle, Karin Berger-Thürmel, Avi Cherla, Kazunori Honda, Christopher C. G. A. Jackson, Deme Karikios, Dario Trapani, Scott Berry, Bishal Gyawali
More posts featuring Bishal Gyawali on OncoDaily.
